1	Hombre	hombre	NCMS000	C0025266#C0086418#C0043210	persona#organismo_vivo	0-6	501_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	7-9	501_QUEST_clinical_caseMIR	SENT1	-	-
3	25	25		-	-	10-12	501_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	13-17	501_QUEST_clinical_caseMIR	SENT1	-	-
5	sin	sin	SPS00	C0332288	atributo	18-21	501_QUEST_clinical_caseMIR	SENT1	-	-
6	antecedentes	antecedente	NCMP000	-	-	22-34	501_QUEST_clinical_caseMIR	SENT1	-	-
7	conocidos	conocer	VMP00PM	-	-	35-44	501_QUEST_clinical_caseMIR	SENT1	-	-
8	de	de	SPS00	C0332285	atributo	45-47	501_QUEST_clinical_caseMIR	SENT1	-	-
9	interés	interés	NCMS000	-	-	48-55	501_QUEST_clinical_caseMIR	SENT1	-	-
10	.	.	Fp	-	-	55-56	501_QUEST_clinical_caseMIR	SENT1	-	-

1	Lleva	llevar	VMIP3S0	-	-	57-62	501_QUEST_clinical_caseMIR	SENT2	-	-
2	2	2		-	-	63-64	501_QUEST_clinical_caseMIR	SENT2	-	-
3	meses	mes	NCMP000	C0439231	calificador	65-70	501_QUEST_clinical_caseMIR	SENT2	-	-
4	con	con	SPS00	C0332287	atributo	71-74	501_QUEST_clinical_caseMIR	SENT2	-	-
5	orinas	orina	NCFP000	C0042036	sustancia	75-81	501_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
6	espumosas	espumoso	AQ0FP0	-	-	82-91	501_QUEST_clinical_caseMIR	SENT2	I-Grp_Enfermedad	-
7	y	y	CC	C1706368	calificador	92-93	501_QUEST_clinical_caseMIR	SENT2	-	-
8	cargadas	cargar	VMP00PF	-	-	94-102	501_QUEST_clinical_caseMIR	SENT2	-	-
9	,	,	Fc	-	-	102-103	501_QUEST_clinical_caseMIR	SENT2	-	-
10	sin	sin	SPS00	C0332288	atributo	104-107	501_QUEST_clinical_caseMIR	SENT2	-	-
11	otra	otro	DI0FS0	C0205394#C0449210	calificador#estructura_corporal	108-112	501_QUEST_clinical_caseMIR	SENT2	-	-
12	sintomatología	sintomatología	NCFS000	-	-	113-127	501_QUEST_clinical_caseMIR	SENT2	-	-
13	.	.	Fp	-	-	127-128	501_QUEST_clinical_caseMIR	SENT2	-	-

1	Exploración	exploración	NCFS000	C0031809_1	procedimiento_1	129-140	501_QUEST_clinical_caseMIR	SENT3	-	-
2	física	físico	NCFS000	C0031809_2	procedimiento_2	141-147	501_QUEST_clinical_caseMIR	SENT3	-	-
3	sin	sin	SPS00	C0332288	atributo	148-151	501_QUEST_clinical_caseMIR	SENT3	-	-
4	hallazgos	hallazgo	NCMP000	C0243095	hallazgo	152-161	501_QUEST_clinical_caseMIR	SENT3	-	-
5	.	.	Fp	-	-	161-162	501_QUEST_clinical_caseMIR	SENT3	-	-

1	Orina	orina	NCFS000	C0042036	sustancia	163-168	501_QUEST_clinical_caseMIR	SENT4	-	-
2	elemental	elemental	AQ0CS0	-	-	169-178	501_QUEST_clinical_caseMIR	SENT4	-	-
3	.	.	Fp	-	-	178-179	501_QUEST_clinical_caseMIR	SENT4	-	-
4	pH	logaritmo_negativo_del_ion_hidrógeno_activo_(símbolo_utilizado_para_expresar_la_acidez_o_alcalinidad_de_una_solución)	NC00YL0	-	-	180-182	501_QUEST_clinical_caseMIR	SENT4	-	-
5	5	5		-	-	183-184	501_QUEST_clinical_caseMIR	SENT4	-	-
6	;	;	Fx	-	-	184-185	501_QUEST_clinical_caseMIR	SENT4	-	-
7	glucosa	glucosa	NCFS000	C0017725	sustancia#producto	186-193	501_QUEST_clinical_caseMIR	SENT4	-	-
8	-	-	Fg	-	-	194-195	501_QUEST_clinical_caseMIR	SENT4	-	-
9	;	;	Fx	-	-	195-196	501_QUEST_clinical_caseMIR	SENT4	-	-
10	hemoglobina	hemoglobina	NCFS000	C0019046	sustancia	197-208	501_QUEST_clinical_caseMIR	SENT4	-	-
11	+	+	Fz	-	-	209-210	501_QUEST_clinical_caseMIR	SENT4	-	-
12	+	+	Fz	-	-	210-211	501_QUEST_clinical_caseMIR	SENT4	-	-
13	;	;	Fx	-	-	211-212	501_QUEST_clinical_caseMIR	SENT4	-	-
14	proteínas	proteína	NCFP000	C0033684	sustancia	213-222	501_QUEST_clinical_caseMIR	SENT4	-	-
15	+	+	Fz	-	-	223-224	501_QUEST_clinical_caseMIR	SENT4	-	-
16	+	+	Fz	-	-	224-225	501_QUEST_clinical_caseMIR	SENT4	-	-
17	;	;	Fx	-	-	225-226	501_QUEST_clinical_caseMIR	SENT4	-	-
18	esterasa	esterasa	NCFS000	C0125619_1	sustancia_1	227-235	501_QUEST_clinical_caseMIR	SENT4	-	-
19	leucocitaria	leucocitario	AQ0FS0	C0125619_2	sustancia_2	236-248	501_QUEST_clinical_caseMIR	SENT4	-	-
20	-	-	Fg	-	-	249-250	501_QUEST_clinical_caseMIR	SENT4	-	-
21	;	;	Fx	-	-	250-251	501_QUEST_clinical_caseMIR	SENT4	-	-
22	proteinuria	proteinuria	NCFS000	C0033687_1	hallazgo_1	252-263	501_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	-
23	1,5	1,5		-	-	264-267	501_QUEST_clinical_caseMIR	SENT4	-	-
24	g/24	g/24	Z	-	-	268-272	501_QUEST_clinical_caseMIR	SENT4	-	-
25	horas	h	NCFP000	C0439227	calificador	273-278	501_QUEST_clinical_caseMIR	SENT4	-	-
26	;	;	Fx	-	-	278-279	501_QUEST_clinical_caseMIR	SENT4	-	-
27	Na	noradrenalina	NC00YL0	C0028351	producto#sustancia	280-282	501_QUEST_clinical_caseMIR	SENT4	-	-
28	urinario	urinario	NCMS000	-	-	283-291	501_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
29	60	60		-	-	292-294	501_QUEST_clinical_caseMIR	SENT4	-	-
30	mEq	miliequivalente_(10-3_mol_dividido_por_la_valencia)	NC00YL0	-	-	295-298	501_QUEST_clinical_caseMIR	SENT4	-	-
31	/	/	Fh	-	-	298-299	501_QUEST_clinical_caseMIR	SENT4	-	-
32	L	l	NCFS000	-	-	299-300	501_QUEST_clinical_caseMIR	SENT4	-	-
33	;	;	Fx	-	-	300-301	501_QUEST_clinical_caseMIR	SENT4	-	-
34	K	k	NCFS000	-	-	302-303	501_QUEST_clinical_caseMIR	SENT4	-	-
35	urinario	urinario	NCMS000	-	-	304-312	501_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
36	30	30		-	-	313-315	501_QUEST_clinical_caseMIR	SENT4	-	-
37	mEq	miliequivalente_(10-3_mol_dividido_por_la_valencia)	NC00YL0	-	-	316-319	501_QUEST_clinical_caseMIR	SENT4	-	-
38	/	/	Fh	-	-	319-320	501_QUEST_clinical_caseMIR	SENT4	-	-
39	L	l	NCFS000	-	-	320-321	501_QUEST_clinical_caseMIR	SENT4	-	-
40	;	;	Fx	-	-	321-322	501_QUEST_clinical_caseMIR	SENT4	-	-
41	Cl	centilitro	NCMN000	C0475212	calificador	323-325	501_QUEST_clinical_caseMIR	SENT4	-	-
42	urinario	urinario	NCMS000	-	-	326-334	501_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
43	100	100		-	-	335-338	501_QUEST_clinical_caseMIR	SENT4	-	-
44	mEq	miliequivalente_(10-3_mol_dividido_por_la_valencia)	NC00YL0	-	-	339-342	501_QUEST_clinical_caseMIR	SENT4	-	-
45	/	/	Fh	-	-	342-343	501_QUEST_clinical_caseMIR	SENT4	-	-
46	L.	l.	NCFS000	-	-	343-345	501_QUEST_clinical_caseMIR	SENT4	-	-
47	Bioquímica	bioquímico	NCFS000	C0205474#C0175854	calificador#ocupación	346-356	501_QUEST_clinical_caseMIR	SENT4	-	-
48	sanguínea	sanguíneo	AQ0FS0	-	-	357-366	501_QUEST_clinical_caseMIR	SENT4	-	-
49	.	.	Fp	-	-	366-367	501_QUEST_clinical_caseMIR	SENT4	-	-
50	creatinina	creatinina	NC00SC0	C0010294	sustancia	368-378	501_QUEST_clinical_caseMIR	SENT4	-	-
51	1,6	1.6	Z	-	-	379-382	501_QUEST_clinical_caseMIR	SENT4	-	-
52	mg	mg	NCMN000	-	-	383-385	501_QUEST_clinical_caseMIR	SENT4	-	-
53	/	/	Fh	-	-	385-386	501_QUEST_clinical_caseMIR	SENT4	-	-
54	dL	decilitro	NCMN000	C0439241	calificador	386-388	501_QUEST_clinical_caseMIR	SENT4	-	-
55	;	;	Fx	-	-	388-389	501_QUEST_clinical_caseMIR	SENT4	-	-
56	urea	urea	NCFS000	C0041942	sustancia	390-394	501_QUEST_clinical_caseMIR	SENT4	-	-
57	80	80	Z	-	-	395-397	501_QUEST_clinical_caseMIR	SENT4	-	-
58	mg	mg	NCMN000	-	-	398-400	501_QUEST_clinical_caseMIR	SENT4	-	-
59	/	/	Fh	-	-	400-401	501_QUEST_clinical_caseMIR	SENT4	-	-
60	dL	decilitro	NCMN000	C0439241	calificador	401-403	501_QUEST_clinical_caseMIR	SENT4	-	-
61	;	;	Fx	-	-	403-404	501_QUEST_clinical_caseMIR	SENT4	-	-
62	Na	noradrenalina	NC00YL0	C0028351	producto#sustancia	405-407	501_QUEST_clinical_caseMIR	SENT4	-	-
63	140	140		-	-	408-411	501_QUEST_clinical_caseMIR	SENT4	-	-
64	mEq	miliequivalente_(10-3_mol_dividido_por_la_valencia)	NC00YL0	-	-	412-415	501_QUEST_clinical_caseMIR	SENT4	-	-
65	/	/	Fh	-	-	415-416	501_QUEST_clinical_caseMIR	SENT4	-	-
66	L	l	NCFS000	-	-	416-417	501_QUEST_clinical_caseMIR	SENT4	-	-
67	;	;	Fx	-	-	417-418	501_QUEST_clinical_caseMIR	SENT4	-	-
68	K3,8	K3,8		-	-	419-423	501_QUEST_clinical_caseMIR	SENT4	-	-
69	mEq	miliequivalente_(10-3_mol_dividido_por_la_valencia)	NC00YL0	-	-	424-427	501_QUEST_clinical_caseMIR	SENT4	-	-
70	/	/	Fh	-	-	427-428	501_QUEST_clinical_caseMIR	SENT4	-	-
71	L.	l.	NCFS000	-	-	428-430	501_QUEST_clinical_caseMIR	SENT4	-	-
72	Estudio	estudio	NCMS000	C0557651	medio_ambiente	431-438	501_QUEST_clinical_caseMIR	SENT4	-	-
73	inmunológico	inmunológico	AQ0MS0	C0205470	calificador	439-451	501_QUEST_clinical_caseMIR	SENT4	-	-
74	.	.	Fp	-	-	451-452	501_QUEST_clinical_caseMIR	SENT4	-	-
75	antiDNA	antidesoxyribonucleic_acid_(ácido_desoxirribonucleico,_adn)	NC00YL0	-	-	453-460	501_QUEST_clinical_caseMIR	SENT4	-	-
76	negativo	negativo	AQ0MS0	C0205160#C0549184	calificador	461-469	501_QUEST_clinical_caseMIR	SENT4	-	-
77	;	;	Fx	-	-	469-470	501_QUEST_clinical_caseMIR	SENT4	-	-
78	ANCA	anca	NCFS000	-	-	471-475	501_QUEST_clinical_caseMIR	SENT4	-	-
79	negativo	negativo	AQ0MS0	C0205160#C0549184	calificador	476-484	501_QUEST_clinical_caseMIR	SENT4	-	-
80	;	;	Fx	-	-	484-485	501_QUEST_clinical_caseMIR	SENT4	-	-
81	antiMBG	antimbg	NCMS000	-	-	486-493	501_QUEST_clinical_caseMIR	SENT4	-	-
82	negativo	negativo	AQ0MS0	C0205160#C0549184	calificador	494-502	501_QUEST_clinical_caseMIR	SENT4	-	-
83	;	;	Fx	-	-	502-503	501_QUEST_clinical_caseMIR	SENT4	-	-
84	factor	factor	NCMS000	C0427391_1	hallazgo_1	504-510	501_QUEST_clinical_caseMIR	SENT4	-	-
85	reumatoide	reumatoide	AQ0CS0	C0427391_2	hallazgo_2	511-521	501_QUEST_clinical_caseMIR	SENT4	-	-
86	negativo	negativo	NCMS000	C0427391_3	hallazgo_3	522-530	501_QUEST_clinical_caseMIR	SENT4	-	-
87	;	;	Fx	-	-	530-531	501_QUEST_clinical_caseMIR	SENT4	-	-
88	C3	C3		-	-	532-534	501_QUEST_clinical_caseMIR	SENT4	-	-
89	20	20	Z	-	-	535-537	501_QUEST_clinical_caseMIR	SENT4	-	-
90	mg	mg	NCMN000	-	-	538-540	501_QUEST_clinical_caseMIR	SENT4	-	-
91	/	/	Fh	-	-	540-541	501_QUEST_clinical_caseMIR	SENT4	-	-
92	dL	decilitro	NCMN000	C0439241	calificador	541-543	501_QUEST_clinical_caseMIR	SENT4	-	-
93	(	(	Fpa	-	-	544-545	501_QUEST_clinical_caseMIR	SENT4	-	-
94	normal	normal	AQ0CS0	C0205307	calificador	545-551	501_QUEST_clinical_caseMIR	SENT4	-	-
95	60-120	60-120		-	-	552-558	501_QUEST_clinical_caseMIR	SENT4	-	-
96	)	)	Fpt	-	-	558-559	501_QUEST_clinical_caseMIR	SENT4	-	-
97	;	;	Fx	-	-	559-560	501_QUEST_clinical_caseMIR	SENT4	-	-
98	C4	C4		-	-	561-563	501_QUEST_clinical_caseMIR	SENT4	-	-
99	10	10	Z	-	-	564-566	501_QUEST_clinical_caseMIR	SENT4	-	-
100	mg	mg	NCMN000	-	-	567-569	501_QUEST_clinical_caseMIR	SENT4	-	-
101	/	/	Fh	-	-	569-570	501_QUEST_clinical_caseMIR	SENT4	-	-
102	dL	decilitro	NCMN000	C0439241	calificador	570-572	501_QUEST_clinical_caseMIR	SENT4	-	-
103	(	(	Fpa	-	-	573-574	501_QUEST_clinical_caseMIR	SENT4	-	-
104	normal	normal	AQ0CS0	C0205307	calificador	574-580	501_QUEST_clinical_caseMIR	SENT4	-	-
105	20-40	20-40		-	-	581-586	501_QUEST_clinical_caseMIR	SENT4	-	-
106	)	)	Fpt	-	-	586-587	501_QUEST_clinical_caseMIR	SENT4	-	-
107	.	.	Fp	-	-	587-588	501_QUEST_clinical_caseMIR	SENT4	-	-

1	Se	se	P00CN000	-	-	589-591	501_QUEST_clinical_caseMIR	SENT5	-	-
2	realiza	realizar	VMIP3S0	-	-	592-599	501_QUEST_clinical_caseMIR	SENT5	-	-
3	biopsia	biopsia	NCFS000	C0194073_1	procedimiento_1	600-607	501_QUEST_clinical_caseMIR	SENT5	-	-
4	renal	renal	AQ0CS0	C0194073_2	procedimiento_2	608-613	501_QUEST_clinical_caseMIR	SENT5	B-Estructura_Corporal	-
5	.	.	Fp	-	-	613-614	501_QUEST_clinical_caseMIR	SENT5	-	-

1	Cuál	cuál	PT0CS000	-	-	615-619	501_QUEST_clinical_caseMIR	SENT6	-	-
2	de	de	SPS00	C0332285	atributo	620-622	501_QUEST_clinical_caseMIR	SENT6	-	-
3	estos	este	DD0MP0	-	-	623-628	501_QUEST_clinical_caseMIR	SENT6	-	-
4	diagnósticos	diagnóstico	NCMP000	C0011900	entidad_observable	629-641	501_QUEST_clinical_caseMIR	SENT6	-	-
5	le	le	PP3CSD00	C1292157#C0409974	hallazgo#trastorno	642-644	501_QUEST_clinical_caseMIR	SENT6	-	-
6	parece	parecer	VMIP3S0	-	-	645-651	501_QUEST_clinical_caseMIR	SENT6	-	-
7	más	más	RG	C0205172	calificador	652-655	501_QUEST_clinical_caseMIR	SENT6	-	-
8	probable	probable	AQ0CS0	C0332148	calificador	656-664	501_QUEST_clinical_caseMIR	SENT6	-	-
9	encontrar	encontrar	VMN0000	-	-	665-674	501_QUEST_clinical_caseMIR	SENT6	-	-
10	en	en	SPS00	C1720294#C0332285	calificador#atributo	675-677	501_QUEST_clinical_caseMIR	SENT6	-	-
11	la	el	DA0FS0	-	-	678-680	501_QUEST_clinical_caseMIR	SENT6	-	-
12	biopsia	biopsia	NCFS000	C0005558	procedimiento#calificador	681-688	501_QUEST_clinical_caseMIR	SENT6	-	-
13	.	.	Fp	-	-	688-689	501_QUEST_clinical_caseMIR	SENT6	-	-

